Hudson Bay Capital Management
NVS icon

Hudson Bay Capital Management’s Novartis NVS Stock Holding History

Hudson Bay Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-114,346
Closed -$15.8M – 1533
2025
Q4 		$15.8M Buy
+114,346
New +$15M 0.05% 258
2025
Q2 		– Sell
-231,567
Closed -$25.8M – 1579
2025
Q1 		$25.8M Buy
231,567
+221,567
+2,216% +$23.6M 0.08% 222
2024
Q4 		$973K Buy
+10,000
New +$1.07M ﹤0.01% 754

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hudson Bay Capital Management's NVS Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 114,346 shares — an estimated $15.8M sold.

Hudson Bay Capital Management first reported a position in NVS in Q4 2024 and held it in 3 quarters. The position peaked at $25.8M in Q1 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 114,346 Novartis shares in Q1 2026, an estimated $15.8M.
  • Hudson Bay Capital Management first reported a position in Novartis in Q4 2024 and held it in 3 quarters.
  • Hudson Bay Capital Management's Novartis position peaked at $25.8M in Q1 2025.
  • 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.